Inflammation in Alzheimer Disease--A Brief Review of the Basic Science and Clinical Literature

Cites (252)

Items 201–252 of 252

1. Ultrastructural localization of complement membrane attack complex (MAC)-like immunoreactivity in brains of patients with Alzheimer's disease
   Shigeru Itagaki, Haruhiko Akiyama, Hiroki Saito, Patrick L. McGeer · 1994 · Brain Research
2. CR1 and CR1‐like: the primate immune adherence receptors
   Daniel J. Birmingham, Lee A. Hebert · 2001 · Immunological Reviews
3. The role of complement in Alzheimer’s disease pathology
   Mark R. Emmerling, M. Desiree Watson, Charlotte A. Raby, Katharyn Spiegel · 2000 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
4. Membrane receptors for soluble defense collagens
   Andrea J. Tenner · 1999 · Current Opinion in Immunology
5. Prevalence of Dementia amongst Elderly Japanese with Leprosy: Apparent Effect of Chronic Drug Therapy
   Patrick L. McGeer, Nobuo Harada, Hiroshi Kimura, Edith G. McGeer, Michael Schulzer · 1992 · Dementia and Geriatric Cognitive Disorders
6. Does aspirin protect against Alzheimer's dementia? A study in a Swedish population-based sample aged ?80�years
   Nilsson, Sven E., Johansson, Boo, Takkinen, Sanna, Zarit, Steven, McClearn, Gerald, Melander, Arne, Berg, Stig · 2003 · European Journal of Clinical Pharmacology
7. A case‐control study of Alzheimer's disease in China
   G. Li, Yu‐Chu Shen, Y. T. Li, C. H. Chen, Y. W. Zhau, Jeremy M. Silverman · 1992 · Neurology
8. Systemic inflammation switches the inflammatory cytokine profile in CNS Wallerian degeneration
   Karine Palin, Colm M. Cunningham, Penny A. Forse, Victor Hugh Perry, Nick Platt · 2007 · Neurobiology of Disease
9. Harnessing the power of gene microarrays for the study of brain aging and Alzheimer's disease: Statistical reliability and functional correlation
   Eric M. Blalock, Kuey-Chu Chen, Arnold J. Stromberg, Christopher Mark Norris, Inga Kadish, Susan D. Kraner, Nada M. Porter, Philip W. Landfield · 2005 · Ageing Research Reviews
10. Expression of complement messenger RNAs and proteins by human oligodendroglial cells
    Masato Hosokawa, Andis Klegeris, John A. Maguire, Patrick L. McGeer · 2003 · Glia
11. Differential expression of individual complement regulators in the brain and choroid plexus.
    S. K. Singhrao, Jim W. Neal, Neil K. Rushmere, B. Paul Morgan, Philippe Gasque · 1999 · PubMed
12. Increased expression of the γ‐secretase components presenilin‐1 and nicastrin in activated astrocytes and microglia following traumatic brain injury
    Yasmine Nadler, Alexander G. Alexandrovich, Nikolaos Grigoriadis, Tobias Hartmann, Kosagi Sharaf Jagannatha Rao, Esther Shohami, Reuven Stein · 2008 · Glia
13. Degradation of fibrillar forms of Alzheimer's amyloid β-peptide by macrophages
    Amitabha Majumdar, Haeyong Chung, Georgia Dolios, Rong Wang, Nikiya Asamoah, Peter Lobel, Frederick R. Maxfield · 2007 · Neurobiology of Aging
14. Evidence linking neuronal cell death to autoimmunity in Alzheimer’s disease
    Michael R. D’Andrea · 2003 · Brain Research
15. Biomarker discovery for Alzheimer’s disease, frontotemporal lobar degeneration, and Parkinson’s disease
    William T. Hu, Alice S. Chen‐Plotkin, Steven Edward Arnold, Murray Grossman, Christopher M. Clark, Leslie M. J. Shaw, Leo F. McCluskey, Lauren B. Elman, Jason H. Karlawish, Howard I. Hurtig et al. · 2010 · Acta Neuropathologica
16. Multifaceted aspects of inflammation in multiple sclerosis: The role of microglia
    Luca Muzio, Gianvito Martino, Roberto Furlan · 2007 · Journal of Neuroimmunology
17. Investigations with cultured human microglia on pathogenic mechanisms of Alzheimer's disease and other neurodegenerative diseases
    Douglas G. Walker, L-F Lue · 2005 · Journal of Neuroscience Research
18. The role of RAGE in amyloid-beta peptide-mediated pathology in Alzheimer's disease.
    Ann Marie Schmidt, Barbara G. Sahagan, Robert B. Nelson, Johan Selmer, Robert Rothlein, Joanne M. Bell · 2009 · PubMed
19. CCAAT/enhancer binding protein δ (C/EBPδ) expression and elevation in Alzheimer’s disease
    Rena Li, Ron Strohmeyer, Zhe Liang, Lih‐Fen Lue, Joseph Rogers · 2004 · Neurobiology of Aging
20. Binding of complement component Clq to myelin oligodendrocyte glycoprotein: A novel mechanism for regulating CNS inflammation
    Terrance G. Johns, Claude C.A. Bernard · 1997 · Molecular Immunology
21. Decreased Fractalkine and Increased IP-10 Expression in Aged Brain of APPswe Transgenic Mice
    Rui‐Sheng Duan, Xin Yang, Zhiguo Chen, Ming‐Ou Lu, Christopher M. Morris, Bengt G. Winblad, Jie Zhu · 2007 · Neurochemical Research
22. Alzheimer's Disease and Rheumatoid Arthritis
    R Myllykangas-Luosujärvi, H. A. Isomäki · 1994 · Lara D. Veeken
23. Overexpression of the Neuritotrophic Cytokine S100β Precedes the Appearance of Neuritic β‐Amyloid Plaques in APPV717F Mice
    Jin G. Sheng, Robert Emil Mrak, Kelly R. Bales, Barbara Cordell, Steven M. Paul, R. A. Jones, S. Woodward, Xue Q. Zhou, John M. McGinness, W. Sue T. Griffin · 2000 · Journal of Neurochemistry
24. Plaque-Associated Overexpression of Insulin-Degrading Enzyme in the Cerebral Cortex of Aged Transgenic Tg2576 Mice With Alzheimer Pathology
    María Celeste Leal, Verónica Berta Dorfman, Agata C Fernández-Gamba, Blas Frangione, Thomas Wısnıewskı, Eduardo Miguel Castaño, Einar M. Sigurdsson, Laura Morelli · 2006 · Journal of Neuropathology & Experimental Neurology
25. Amyloid β-Peptide Directly Induces Spontaneous Calcium Transients, Delayed Intercellular Calcium Waves and Gliosis in Rat Cortical Astrocytes
    Siu-Kei Chow, Diana Xuan Yu, Christopher L. MacDonald, Marius Buibas, Gabriel A. Silva · 2009 · ASN NEURO
26. Amyloid beta peptide-induced corpus callosum damage and glial activation in vivo.
    Nattinee Jantaratnotai, Jae Kyu Ryu, Seung Up Kim, James G. McLarnon · 2003 · PubMed
27. Neuronal localization of C1q in preclinical Alzheimer's disease
    Maria I Fonseca, Claudia H. Kawas, Juan Carlos Troncoso, Andrea J. Tenner · 2003 · Neurobiology of Disease
28. Gene expression profile analysis of lymphocytes from Alzheimer??s patients
    J. K??lm??n, Klára Kitajka, M. P k ski, ??. Zvara, A. Juh aacute sz, G. Vincze, Z. Janka, L. G. Pusk??s · 2005 · Psychiatric Genetics
29. Complement-activated oligodendroglia: A new pathogenic entity identified by immunostaining with antibodies to human complement proteins C3d and C4d
    T. Yamada, Haruhiko Akiyama, Patrick L. McGeer · 1990 · Neuroscience Letters
30. Impaired cognition, sensorimotor gating, and hippocampal long-term depression in mice lacking the prostaglandin E2 EP2 receptor
    Alena V. Savonenko, Pablo Muñoz, Tatiana Melnikova, Q. Wang, Xibin Liang, RICHARD M. BREYER, Thomas Jude Montine, Alfredo Kirkwood, Katrin I. Andreasson · 2009 · Experimental Neurology
31. Aspirin, NSAIDs, Risk of Dementia, and Influence of the Apolipoprotein E Epsilon 4 Allele in an Elderly Population
    Christel Cornelius, Johan Fastbom, Bengt G. Winblad, Matti H. Viitanen · 2004 · Neuroepidemiology
32. Inflammation and Microglia Actions in Alzheimer’s Disease
    Colin Kelly Combs · 2009 · Journal of Neuroimmune Pharmacology
33. Expression of presenilin-1 and -2 mRNAs in rat and Alzheimer's disease brains
    Kenji Takami, Kazuhiro Terai, Akinori Matsuo, Douglas G Walker, Patrick L. McGeer · 1997 · Brain Research
34. Development of microglia in the chick embryo spinal cord: Implications in the regulation of motoneuronal survival and death
    Jordi Calderó, Núria Brunet, Dolors Ciutat, Marta Hereu, Josep Enric Esquerda · 2009 · Journal of Neuroscience Research
35. Non-steroidal anti-inflammatory drug (NSAID) use and Alzheimer disease in community-dwelling elderly patients.
    F. Landi, M. Cesari, G. Onder, A. Russo, Sergio Torre, R. Bernabei · 2003 · The American journal of geriatric psychiatry
36. Gain in Brain Immunity in the Oldest-Old Differentiates Cognitively Normal from Demented Individuals
    Pavel Katsel, Weilun Tan, Vahram H. Haroutunian · 2009 · PLoS ONE
37. Involvement of formyl-peptide-receptor-like-1 and phospholipase D in the internalization and signal transduction of amyloid beta 1-42 in glial cells
    Lars‐Ove Brandenburg, M. Konrad, Christoph Jan Wruck, Thomas Koch, Thomas Pufe, Ralph Lucius · 2008 · Neuroscience
38. 2D gel blood serum biomarkers reveal differential clinical proteomics of the neurodegenerative diseases
    Essam A. Sheta, Stanley H. Appel, Ira L. Goldknopf · 2006 · Expert Review of Proteomics
39. NSAIDs for the Chemoprevention of Alzheimer’s Disease
    Christine A. Szekely, Terrence Town, Peter P. Zandi · 2007 · Sub-cellular biochemistry/Subcellular biochemistry
40. Enhanced susceptibility of S‐100B transgenic mice to neuroinflammation and neuronal dysfunction induced by intracerebroventricular infusion of human β‐amyloid
    Jeffrey M. Craft, Daniel Martin Watterson, Alexander Marks, Linda J. Van Eldik · 2005 · Glia
41. Induction of the Formyl Peptide Receptor 2 in Microglia by IFN-γ and Synergy with CD40 Ligand
    Keqiang Chen, Pablo Iribarren, Jian Huang, Lingzhi Zhang, Wanghua Gong, Edward H. Cho, Stephen Lockett, Nancy M. Dunlop, Ji Ming Wang · 2007 · The Journal of Immunology
42. Rheumatoid arthritis and susceptibility to Alzheimer's disease
    C. Mary Beard, EMRE KOKMAN, LeonardT. Kurland · 1991 · The Lancet
43. A Case-Control Analysis of Nonsteroidal Anti-Inflammatory Drugs and Alzheimer’s Disease: Are They Protective?
    Christina Wolfson, A. Perrault, Y. Moride, J. Esdaile, Lucien Abenhaim, Franco Momoli · 2002 · Neuroepidemiology
44. Microglia in amyotrophic lateral sclerosis.
    Maarten Dewil, Ludo Van Den Bosch, Wim Robberecht · 2007 · PubMed
45. RAGE Does Not Affect Amyloid Pathology in Transgenic ArcAβ Mice
    Vodopivec, Ivana, Galichet, Arnaud, Knobloch, Marlen, Bierhaus, Angelika, Heizmann, Claus W., Nitsch, Roger M. · 2009 · Neurodegenerative Diseases
46. Complement receptors and regulatory proteins: immune adherence revisited and abuse by microorganisms
    John Atkinson, Malgorzata Krych, M W Nickells · 1994 · Clinical & Experimental Immunology
47. Binding of complement component C1q to myelin oligodendrocyte glycoprotein: A novel mechanism for regulating CNS inflammation
    Terrance G. Johns, Claude C.A. Bernard · 1998 · Journal of Neuroimmunology
48. Non-Steroidal Anti-Inflammatory Drug (NSAID) Use and Alzheimer Disease in Community-Dwelling Elderly Patients
    F. Landi · 2003 · American Journal of Geriatric Psychiatry
49. Human oligodendroglial cells express low levels of C1 inhibitor and membrane cofactor protein mRNAs.
    Masato Hosokawa, Andis Klegeris, Patrick L. McGeer · 2004 · Journal of Neuroinflammation
50. The MHP36 line of murine neural stem cells expresses functional CXCR1 chemokine receptors that initiate chemotaxis in vitro
    Cedric S. Raine · 2007 · Journal of Neuroimmunology
51. Effects of Rofecoxib or Naproxen vs Placebo on Alzheimer Disease Progression: A Randomized Controlled Trial
    Aisen, Paul S., Schafer, Kimberly A., Grundman, Michael, Pfeiffer, Eric, Sano, Mary, Davis, Kenneth L., Farlow, Martin R., Jin, Shelia, Thomas, Ronald G., Thal, Leon J. et al. · 2003 · JAMA
52. Deletion of tumor necrosis factor death receptor inhibits amyloid β generation and prevents learning and memory deficits in Alzheimer's mice
    Ping He, Zhenyu Zhong, Kristina Lindholm, Lilian Berning, Wendy Lee, Cynthia Ann Lemere, Matthias Staufenbiel, Rena Li, Yong Shen · 2007 · The Journal of Experimental Medicine